Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection
Aml Mohamed Soliman, Ramadan Ghaleb, Amr H. Mahmoud, Mustafa Al-Hassan Abdou Heidar, Ayman Ibrahim
Springer Nature ·
2026-04-22
· DOI 10.1186/s12872-026-05819-4
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Aml Mohamed Soliman, Ramadan Ghaleb, Amr H. Mahmoud, Mustafa Al-Hassan Abdou Heidar, Ayman Ibrahim. Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection. // BMC Cardiovascular Disorders. – 2026. – DOI: 10.1186/s12872-026-05819-4. – URL: https://doi.org/10.1186/s12872-026-05819-4
Aml Mohamed Soliman, Ramadan Ghaleb, Amr H. Mahmoud, Mustafa Al-Hassan Abdou Heidar, & Ayman Ibrahim (2026). Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-026-05819-4
Aml Mohamed Soliman, et al. “Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection.” BMC Cardiovascular Disorders, 2026. doi:10.1186/s12872-026-05819-4.
@article{Soliman2026,
title = {Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection},
author = {Soliman, Aml Mohamed and Ghaleb, Ramadan and Mahmoud, Amr H. and Heidar, Mustafa Al-Hassan Abdou and Ibrahim, Ayman},
journal = {BMC Cardiovascular Disorders},
year = {2026},
doi = {10.1186/s12872-026-05819-4},
url = {https://doi.org/10.1186/s12872-026-05819-4}
}